PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS

PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS

Bibliographic Details
Main Authors:	Robson, J, Kiran, A, Maskell, J, Arden, N, Hutchings, A, Emin, A, Culliford, D, Dasgupta, B, Hamilton, W, Luqmani, R
Format:	Conference item
Published:	2013

Similar Items

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2013)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
by: Robson, J, et al.
Published: (2015)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2015)

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study
by: Robson, J, et al.
Published: (2016)

THU0297 A novel ultrasound scoring system for giant cell arteritis
by: Monti, S, et al.
Published: (2017)

THU0302 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the tabul study (temporal artery biopsy vs ultrasound in diagnosis of giant cell arteritis)
by: Ponte, C, et al.
Published: (2017)

P1_41 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the TABUL study (Temporal Artery Biopsy vs Ultrasound in diagnosis of Giant Cell Arteritis)
by: Ponte, C, et al.
Published: (2017)

The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS
by: Monti, S, et al.
Published: (2017)

Giant cell arteritis: Current treatment and management
by: Ponte, C, et al.
Published: (2015)

Vascular Endothelial Growth Factor as an Aid to Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

The association of vascular risk factors with visual loss in giant cell arteritis
by: Yates, M, et al.
Published: (2016)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
by: Goodfellow, N, et al.
Published: (2017)

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

FRI0028 Vascular Endothelial Growth Factor as An Aid To Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

O08 Blindness in patients with giant cell arteritis and its association with vascular disease
by: Yates, M, et al.
Published: (2016)

Giant cell arteritis: new concepts, treatments and the unmet need that remains
by: Coath, F, et al.
Published: (2018)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

ARE WE MEETING THE STANDARDS FOR TEMPORAL ARTERY BIOPSY IN GIANT CELL ARTERITIS?
by: Soni, A, et al.
Published: (2009)

GIANT-CELL ARTERITIS WITH PERIPHERAL NEUROPATHY
by: Warrell, D, et al.
Published: (1968)

Giant-cell arteritis with peripheral neuropathy.
by: Warrell, D, et al.
Published: (1968)

Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?
by: Luqmani, R
Published: (2007)

The role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
by: Luqmani, R
Published: (2008)

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

Methotrexate (MTX) failed to control giant cell arteritis (GCA)
by: Hoffman, G, et al.
Published: (2001)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
by: Luqmani, R, et al.
Published: (2017)

The use of ultrasound to assess giant cell arteritis: Review of the current evidence and practical guide for the rheumatologist
by: Monti, S, et al.
Published: (2017)

Giant cell arteritis with panocular involvement in an Indian male
by: Jaais, Fathilah, et al.
Published: (2003)

Carbon monoxide poisoning masquerading as giant cell arteritis
by: Xue, K, et al.
Published: (2012)

Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis.
by: Bowness, P, et al.
Published: (1991)

The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
by: Luqmani, R, et al.
Published: (2016)

ROS producing immature neutrophils in Giant Cell Arteritis are linked to vascular pathologies
by: Wang, L, et al.
Published: (2020)

THU0296 The role of ultrasound in the management of giant cell arteritis (GCA) in routine clinical practice
by: Monti, S, et al.
Published: (2017)

A multinational qualitative study in giant cell arteritis: patient perceptions of diagnosis, treatment, impact on health-related quality of life and contextual factors
by: Robson, J, et al.
Published: (2018)

Giant cell arteritis-where did we go wrong?
by: Devaraj, Navin Kumar
Published: (2019)

The role of a standardised ultrasound protocol in the management of giant cell arteritis (GCA) in routine clinical practice
by: Monti, S, et al.
Published: (2017)

Inflammatory Mediators in Abdominal Aortic Aneurysms
by: Cassimjee, I, et al.
Published: (2017)

A multicenter placebo-controlled study of methotrexate (MTX) in giant cell arteritis (GCA).
by: Hoffman, G, et al.
Published: (2000)